- not yet recruitingPHASE2
Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors
This study looks at using heat treatment (hyperthermia) with repeat radiation therapy for certain cancers that have come back after earlier radiation. It checks if this combined approach works as well as the first treatment for preventing the cancer from returning locally.
Germany - recruiting
Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker
This study looks at how we measure physical activity in people with lymphoma, pancreatic, or bowel cancer. It compares questionnaires with motion trackers to see which works best. The aim is to find better ways to understand how active cancer patients are.
Germany - recruitingNA
Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX
This study looks at treating pancreatic cancer that has spread to the liver. We want to see if surgery to remove both the main tumour and the liver spots after special chemotherapy called FOLFIRINOX can help patients. It's a small study hoping to improve care.
Canada - recruitingPHASE4
Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
This study compares when to give blood clot prevention medicine for pancreatic surgery: either before or after the operation. It aims to find the safest and most effective timing to reduce risks like blood clots and bleeding. This is important because current guidelines differ.
Canada · Finland · Norway - recruiting
PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
This study, called PaCaReg, is gathering information from people newly diagnosed with a common type of pancreatic cancer. Doctors want to learn more about how the disease affects people and how it's treated in real life. It's not a study testing a new medicine, but rather collecting details to help improve care.
Germany - recruitingPHASE1
A Study of MGC026 in Participants With Advanced Solid Tumors
This study is testing a new medicine called MGC026 for people with advanced cancers that have come back or spread. Doctors want to see if it's safe, what side effects it causes, and if it can help slow down or shrink tumors.
United States · Australia · United Kingdom - recruiting
Pancreatic Cancer Early Detection Consortium
This study aims to find better ways to spot pancreatic cancer early, especially in people with a higher risk due to family history or specific genetic changes. Researchers will collect health information and samples over time to understand how the disease develops.
United States · Australia · Canada - recruitingPHASE1
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
This early-stage study is testing a new drug, MOMA-313, for advanced solid tumours, including prostate, breast, and pancreatic cancers. It aims to find a safe dose and see how it works, either alone or with another drug called Olaparib, in patients whose tumours have a specific genetic weakness.
United States · Spain · United Kingdom